Consolidated Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 13,056,000	$ 11,609,000
Tax credit receivable	3,351,000	3,228,000
Prepaid expenses and other current assets	1,060,000	1,444,000
Total Current Assets	17,467,000	16,281,000
Non-Current Assets
Property and equipment, net	222,000	270,000
Restricted cash	46,000	96,000
Right of use asset	803,000	1,272,000
In-process research and development	19,619,000	17,358,000
Deposits and other assets	82,000	75,000
Total Assets	38,239,000	35,352,000
Current Liabilities:
Accounts payable	1,014,000	859,000
Accrued expenses	6,276,000	3,368,000
Accrued employee benefits	443,000	1,144,000
Deferred research and development tax credit-current portion	1,675,000	1,614,000
Loans payable-current	57,000	61,000
Operating lease liability-current portion	549,000	539,000
Total Current Liabilities	10,014,000	7,585,000
Non-current Liabilities
Non-current contingent consideration	10,004,000	6,973,000
Loan Payable - non-current	1,671,000	92,000
Non-current deferred research and development tax credit	815,000	762,000
Non-current operating lease liability	352,000	873,000
Total Liabilities	22,856,000	16,285,000
Commitments and Contingencies (Note 12)
Stockholders' Equity:
Common stock, $0.001 par value; 350,000,000 shares authorized, 35,717,159 issued and 35,688,350 outstanding at December 31, 2025 and 2,811,259 issued and 2,782,449 outstanding at December 31, 2024	34,000	3,000
Additional paid-in capital	373,592,000	355,501,000
Treasury stock at cost, 28,809 shares at December 31, 2025 and at December 31, 2024	(288,000)	(288,000)
Accumulated other comprehensive income (loss)	755,000	(1,178,000)
Accumulated deficit	(358,710,000)	(334,971,000)
Total Stockholders' Equity	15,383,000	19,067,000
Total Liabilities and Stockholders' Equity	$ 38,239,000	$ 35,352,000